Shuttle Pharmaceuticals (US:SHPH)2024-03-22 13:00Company Overview - Shuttle Pharmaceuticals Holdings, Inc. filed its Annual Report on Form 10-K for the year ended December 31, 2023, on March 22, 2024[5]. - The company is classified as an emerging growth company under the Securities Act of 1933[4]. - The company’s common stock is traded on The Nasdaq Stock Market under the symbol SHPH[3]. - The address of the principal executive offices is 401 Professional Drive, Suite 260, Gaithersburg, MD 20879[2]. Financial Information - The press release dated March 22, 2024, provides a corporate update, although specific financial results are not detailed in the provided content[5]. - The report does not include specific performance metrics or user data in the provided content[5]. - There is no mention of future outlook, product development, market expansion, or mergers and acquisitions in the available information[5]. - The filing does not indicate any new strategies or financial guidance for the upcoming periods[5]. Document Details - The document includes a signature from the CEO, Anatoly Dritschilo, confirming the report[10]. - The information in the filing is not deemed "filed" for purposes of the Exchange Act, indicating it may be used in future filings[6].